Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer’s disease in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort-Reference-Cited by-同舟云学术

Associations of circulating saturated long-chain fatty acids with risk of mild cognitive impairment and Alzheimer’s disease in the Alzheimer’s Disease Neuroimaging Initiative (ADNI) cohort

Published:2023-11 Issue: Volume:97 Page:104818
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Fan Lei,Borenstein Amy R.,Wang Sophia,Nho Kwangsik,Zhu Xiangzhu,Wen Wanqing,Huang Xiang,Mortimer James A.,Shrubsole Martha J.,Dai Qi^ORCID

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference37 articles.

1. Mortality rates in Alzheimer’s disease and non-Alzheimer’s dementias: a systematic review and meta-analysis;Liang;Lancet Healthy Longev,2021

2. The value of delaying alzheimer’s disease onset;Zissimopoulos;Forum Health Econ Policy,2015

3. Projections of Alzheimer’s disease in the United States and the public health impact of delaying disease onset;Brookmeyer;Am J Public Health,1998

4. Biofluid-based biomarkers for Alzheimer’s disease-related pathologies: an update and synthesis of the literature;Zetterberg;Alzheimers Dement,2022

5. Mechanisms of action for the medium-chain triglyceride ketogenic diet in neurological and metabolic disorders;Augustin;Lancet Neurol,2018

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential therapeutic natural compounds for the treatment of Alzheimer's disease;Phytomedicine;2024-09

2. The Association Between Surgery and Mild Cognitive Impairment: Insight from a Case-Control Study;Journal of Alzheimer's Disease;2024-08-13

3. The vascular contribution of apolipoprotein E to Alzheimer’s disease;Brain;2024-05-15

4. Mouse serum albumin induces neuronal apoptosis and tauopathies;Acta Neuropathologica Communications;2024-04-23

5. Drug Repurposing in CNS Disorders;Drug Repurposing;2024